Shilpa Medicare Limited (SHILPAMED) — Announcement | 24 June 2026

StockFin.ai

Try Free

Shilpa Medicare announced that its subsidiary Shilpa Biologicals settled a legal dispute with Sartorius Stedim India by paying Rs.9 million in court-ordered settlement, resolving claims of Rs.20.13 million plus interest. The agreement was executed on 23 June 2026 before the XI Addl. City Civil and Sessions Court in Bengaluru, with minimal financial impact limited to the settlement amount. This action satisfies SEBI disclosure requirements under Regulation 30.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SHILPAMED ✨ Ask AI About This

About Shilpa Medicare Limited (SHILPAMED)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹9,356.63 Cr P/E: 106.1

View full SHILPAMED stock details →

📡 Get AI alerts when SHILPAMED files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SHILPAMED — Free

💡 Ask AI about this filing

"How does this announcement affect Shilpa Medicare Limited's outlook?" "What did Shilpa Medicare Limited announce on 24 June 2026?" "Is this positive or negative for SHILPAMED?"

Ask AI Free →

📊 More SHILPAMED filings

See all SHILPAMED filings →

🔥 Also filed on 24 June 2026

RAYMONDREL Raymond Realty Limited Annual Report QUICKHEAL Quick Heal Technologies Limited Corporate Action PVP PVP Ventures Limited Corporate Action PRECAM Precision Camshafts Limited Financial Results RAYMOND Raymond Limited Annual Report REGAAL Regaal Resources Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when SHILPAMED files new disclosures

Track SHILPAMED filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SHILPAMED — Free

Free account · 2 AI queries/day